Simulations Plus Inc (SLP) is a Healthcare · Health Information Services company listed on NASDAQ. Price $18.44 (+0.05%), Market cap $0.30B, 52-week low–high $11.36 ~ $34.35.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, E
Financial statements, price targets, institutional (13F) holdings and related news for Simulations Plus Inc are updated in real time on BlackAll Trade.
Simulations Plus Inc trades at $18.44 (+0.05%). Real-time quotes and charts are available on BlackAll Trade.
Simulations Plus Inc has a market cap of about $0.30B.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based